Trends in Influenza-Associated Lower Respiratory Tract Infection Burden and Influenza Vaccination Coverage among Adults Aged ≥55 Years in China, 1990–2023

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Influenza-associated lower respiratory tract infections (LRTI) impose substantial disease burden on older populations globally. While China has experienced rapid aging, comprehensive assessment of long-term trends in influenza-associated LRTI burden and vaccination coverage among adults aged ≥55 years remains limited.

Methods

We extracted age-standardized mortality and disability-adjusted life years (DALYs) rates of influenza-associated LRTI among Chinese adults aged ≥55 years from the Global Burden of Disease Study 2023 (GBD 2023). Estimated annual percentage change (EAPC) and age-period-cohort (APC) models were employed to analyze long-term trends (1990–2023). Using the China Health and Retirement Longitudinal Study 2020 (CHARLS 2020, n=13,815), we performed multivariable logistic regression to identify factors associated with influenza vaccination uptake. Spearman correlation assessed ecological associations between GBD age-specific mortality rates and CHARLS vaccination coverage across nine age groups.

Results

Age-standardized mortality rates declined from 4.09 to 0.31 per 100,000 (EAPC=-8.02%, 95%CI: −9.08% to −6.95%), and DALYs rates from 177.63 to 6.06 per 100,000 (EAPC=-10.67%), representing >96% reductions from 1990 to 2023. Deaths dropped sharply by 59.6% in 2020, consistent with protective effects of non-pharmaceutical interventions during COVID-19. The ≥85-year age group showed the slowest improvement (EAPC=-5.63%). Influenza vaccination coverage in CHARLS 2020 was only 15.1%. Older age (≥85 years: OR=0.65, 95%CI: 0.46–0.92) and higher educational attainment (college or above: OR=0.34, 95%CI: 0.20–0.56) were independently associated with lower vaccination rates, though the small sample size in the highest education group (n=68) warrants cautious interpretation. Ecological analysis revealed a significant negative correlation between GBD mortality rates and CHARLS vaccination coverage (r=-0.700, p=0.036, n=9 age groups), indicating a “protection mismatch” phenomenon. Raising vaccination coverage to 75% (WHO target) could prevent approximately 2,041 deaths annually under moderate vaccine efficacy assumptions, with ≥75-year-olds contributing 82.7% of preventable deaths.

Conclusions

Influenza-associated LRTI burden has declined substantially among Chinese adults aged ≥55 years, but improvement is slowest in the oldest age groups. Vaccination coverage remains critically insufficient with a persistent “protection mismatch” where those at highest mortality risk have lowest coverage. Adults aged ≥75 years face a “triple vulnerability” of high mortality, low vaccination coverage, and high COPD comorbidity prevalence, and should be prioritized for vaccination to maximize preventable mortality benefits.

Article activity feed